Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy

Despite modern treatment approaches, survival of patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) remains low and it is difficult to identify patients who derive optimal benefit from treatment. We therefore analyzed which commonly available laboratory and cl...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Main Authors: Magnes, Teresa, Melchardt, Thomas, Weiss, Lukas, Mittermair, Christof, Neureiter, Daniel, Klieser, Eckhard, Gampenrieder, Simon, Moser, Gerhard, Gaggl, Alexander, Greil, Richard, Egle, Alexander
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2017
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5501656/
https://ncbi.nlm.nih.gov/pubmed/28686697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0180995
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares